Aviance Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History
Bought
Maintained
Sold
Aviance Capital Management's OPTR Position: Q4 2013 in Review
Aviance Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 184 shares — an estimated $2K sold.
Aviance Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.
- Aviance Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
- Aviance Capital Management sold 184 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2K.
- Aviance Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
- Aviance Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2K in Q3 2013.
- 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.
Based on Aviance Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.